CA2391571A1 - Procede d'identification rapide et precise de micro-organismes - Google Patents
Procede d'identification rapide et precise de micro-organismes Download PDFInfo
- Publication number
- CA2391571A1 CA2391571A1 CA002391571A CA2391571A CA2391571A1 CA 2391571 A1 CA2391571 A1 CA 2391571A1 CA 002391571 A CA002391571 A CA 002391571A CA 2391571 A CA2391571 A CA 2391571A CA 2391571 A1 CA2391571 A1 CA 2391571A1
- Authority
- CA
- Canada
- Prior art keywords
- primer
- target sequence
- sequence
- oligonucleotide
- organism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 95
- 244000005700 microbiome Species 0.000 title abstract description 18
- 239000000523 sample Substances 0.000 claims abstract description 188
- 238000009396 hybridization Methods 0.000 claims abstract description 82
- 241000894006 Bacteria Species 0.000 claims abstract description 45
- 230000003321 amplification Effects 0.000 claims abstract description 42
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 42
- 241000700605 Viruses Species 0.000 claims abstract description 29
- 238000005859 coupling reaction Methods 0.000 claims abstract description 29
- 230000008878 coupling Effects 0.000 claims abstract description 27
- 238000010168 coupling process Methods 0.000 claims abstract description 27
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 24
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 24
- 239000002157 polynucleotide Substances 0.000 claims abstract description 24
- 239000011521 glass Substances 0.000 claims abstract description 22
- 239000012472 biological sample Substances 0.000 claims abstract description 18
- 241000894007 species Species 0.000 claims abstract description 18
- 230000001965 increasing effect Effects 0.000 claims abstract description 9
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims abstract description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 6
- 239000002751 oligonucleotide probe Substances 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 96
- 108091034117 Oligonucleotide Proteins 0.000 claims description 75
- 102000004169 proteins and genes Human genes 0.000 claims description 68
- 239000007787 solid Substances 0.000 claims description 34
- 239000002773 nucleotide Substances 0.000 claims description 33
- 125000003729 nucleotide group Chemical group 0.000 claims description 32
- 108010055016 Rec A Recombinases Proteins 0.000 claims description 24
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 24
- 230000000295 complement effect Effects 0.000 claims description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 22
- 102000001218 Rec A Recombinases Human genes 0.000 claims description 20
- 238000000018 DNA microarray Methods 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 15
- 230000003612 virological effect Effects 0.000 claims description 12
- 239000004593 Epoxy Substances 0.000 claims description 11
- 230000002441 reversible effect Effects 0.000 claims description 10
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 241000606124 Bacteroides fragilis Species 0.000 claims description 8
- 241000206602 Eukaryota Species 0.000 claims description 8
- 241000711920 Human orthopneumovirus Species 0.000 claims description 8
- 239000004677 Nylon Substances 0.000 claims description 7
- 229920001778 nylon Polymers 0.000 claims description 7
- 208000035475 disorder Diseases 0.000 claims description 6
- 238000005421 electrostatic potential Methods 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 206010036790 Productive cough Diseases 0.000 claims description 2
- 241000223104 Trypanosoma Species 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000013307 optical fiber Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 210000004910 pleural fluid Anatomy 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 208000024794 sputum Diseases 0.000 claims description 2
- 210000003802 sputum Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 23
- 241000233866 Fungi Species 0.000 abstract description 11
- 239000013615 primer Substances 0.000 description 252
- 238000003752 polymerase chain reaction Methods 0.000 description 121
- 238000006243 chemical reaction Methods 0.000 description 68
- 239000000047 product Substances 0.000 description 51
- 244000052769 pathogen Species 0.000 description 44
- 108020004414 DNA Proteins 0.000 description 41
- 241000588724 Escherichia coli Species 0.000 description 28
- 150000007523 nucleic acids Chemical class 0.000 description 28
- 102000039446 nucleic acids Human genes 0.000 description 23
- 108020004707 nucleic acids Proteins 0.000 description 23
- 230000001717 pathogenic effect Effects 0.000 description 18
- 208000015181 infectious disease Diseases 0.000 description 16
- 108091026890 Coding region Proteins 0.000 description 14
- 241000193998 Streptococcus pneumoniae Species 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 241000222122 Candida albicans Species 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 238000013461 design Methods 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 238000002493 microarray Methods 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 201000009906 Meningitis Diseases 0.000 description 9
- 206010035664 Pneumonia Diseases 0.000 description 9
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 241000726041 Human respirovirus 1 Species 0.000 description 8
- 241000589242 Legionella pneumophila Species 0.000 description 8
- 241000588653 Neisseria Species 0.000 description 8
- 241000725643 Respiratory syncytial virus Species 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 8
- 108091036078 conserved sequence Proteins 0.000 description 8
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229940115932 legionella pneumophila Drugs 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 241000228230 Aspergillus parasiticus Species 0.000 description 6
- 241001647372 Chlamydia pneumoniae Species 0.000 description 6
- 241000194032 Enterococcus faecalis Species 0.000 description 6
- 241000606768 Haemophilus influenzae Species 0.000 description 6
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 6
- 108091093037 Peptide nucleic acid Proteins 0.000 description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 6
- 206010040047 Sepsis Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 229940095731 candida albicans Drugs 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 210000003527 eukaryotic cell Anatomy 0.000 description 6
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 210000004379 membrane Anatomy 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 108091092195 Intron Proteins 0.000 description 5
- 241000588650 Neisseria meningitidis Species 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 108090000704 Tubulin Proteins 0.000 description 5
- 238000002405 diagnostic procedure Methods 0.000 description 5
- 229940032049 enterococcus faecalis Drugs 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 229940047650 haemophilus influenzae Drugs 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- -1 nucleoside triphosphates Chemical class 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 4
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- 241000588747 Klebsiella pneumoniae Species 0.000 description 4
- 206010027202 Meningitis bacterial Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000204031 Mycoplasma Species 0.000 description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
- 206010040070 Septic Shock Diseases 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 238000000376 autoradiography Methods 0.000 description 4
- 201000009904 bacterial meningitis Diseases 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 241001493065 dsRNA viruses Species 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229940045505 klebsiella pneumoniae Drugs 0.000 description 4
- 238000007403 mPCR Methods 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 241000588921 Enterobacteriaceae Species 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 3
- 208000007764 Legionnaires' Disease Diseases 0.000 description 3
- 241000588621 Moraxella Species 0.000 description 3
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 description 3
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 3
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 3
- 241000607598 Vibrio Species 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000003068 molecular probe Substances 0.000 description 3
- 238000007857 nested PCR Methods 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 230000036303 septic shock Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 208000019206 urinary tract infection Diseases 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 239000012103 Alexa Fluor 488 Substances 0.000 description 2
- ZAINTDRBUHCDPZ-UHFFFAOYSA-M Alexa Fluor 546 Chemical compound [H+].[Na+].CC1CC(C)(C)NC(C(=C2OC3=C(C4=NC(C)(C)CC(C)C4=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C(=C(Cl)C=1Cl)C(O)=O)=C(Cl)C=1SCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ZAINTDRBUHCDPZ-UHFFFAOYSA-M 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241001235200 Haemophilus influenzae Rd KW20 Species 0.000 description 2
- 241000589989 Helicobacter Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 241000186362 Mycobacterium leprae Species 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 101710183280 Topoisomerase Proteins 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 241000607493 Vibrionaceae Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000033077 cellular process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000010227 enterocolitis Diseases 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108700022487 rRNA Genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 208000000143 urethritis Diseases 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 229940118696 vibrio cholerae Drugs 0.000 description 2
- PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical group NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
- 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241001458906 Alysiella Species 0.000 description 1
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 1
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108010037833 Bacterial Adhesins Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- 208000031462 Bovine Mastitis Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000588877 Eikenella Species 0.000 description 1
- 108090000407 Elongation factor 4 Proteins 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010061974 Gastrointestinal obstruction Diseases 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108010062347 HLA-DQ Antigens Proteins 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 241000893570 Hendra henipavirus Species 0.000 description 1
- 101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
- 108700039795 Human parainfluenza virus 2 L Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 241001454354 Kingella Species 0.000 description 1
- 108010065602 L Protein parainfluenza 3 virus Proteins 0.000 description 1
- 241000589246 Legionellaceae Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010024774 Localised infection Diseases 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 206010058780 Meningitis neonatal Diseases 0.000 description 1
- 241001478292 Moraxella caviae Species 0.000 description 1
- 241001478293 Moraxella cuniculi Species 0.000 description 1
- 241001148188 Moraxella ovis Species 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000588654 Neisseria cinerea Species 0.000 description 1
- 241000588651 Neisseria flavescens Species 0.000 description 1
- 241000588649 Neisseria lactamica Species 0.000 description 1
- 241000588659 Neisseria mucosa Species 0.000 description 1
- 241000588660 Neisseria polysaccharea Species 0.000 description 1
- 241000588645 Neisseria sicca Species 0.000 description 1
- 241001136170 Neisseria subflava Species 0.000 description 1
- 241001135519 Neisseria weaveri Species 0.000 description 1
- 241000588656 Neisseriaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 241000606752 Pasteurellaceae Species 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000233872 Pneumocystis carinii Species 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000863011 Simonsiella Species 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 102100033095 Translation factor GUF1, mitochondrial Human genes 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 108010093857 Viral Hemagglutinins Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 201000005008 bacterial sepsis Diseases 0.000 description 1
- 208000036815 beta tubulin Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000006824 bubonic plague Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000024321 chromosome segregation Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 208000001606 epiglottitis Diseases 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 244000078673 foodborn pathogen Species 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000027096 gram-negative bacterial infections Diseases 0.000 description 1
- 102000056838 human CDK1 Human genes 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000002650 immunosuppressive therapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000009424 underpinning Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne des procédés et des compositions utilisés pour l'identification rapide de micro-organismes. L'invention concerne également des procédés et des compositions servant à l'identification rapide et simultanée dans un échantillon biologique de multiples micro-organismes, comportant des bactéries, des champignons, des virus et de la levure. L'invention fait également état de procédés et de compositions employant de techniques d'amplification et d'hybridation de séquence spécifique, afin de détecter d'une séquence de polynucléotide spécifique d'une espèce dans un échantillon. L'invention présente aussi de nouveaux procédés associant des sondes d'oligonucléotides à des surfaces en verre à l'efficacité améliorée.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16588199P | 1999-11-16 | 1999-11-16 | |
| US60/165,881 | 1999-11-16 | ||
| US47945700A | 2000-01-06 | 2000-01-06 | |
| US09/479,457 | 2000-01-06 | ||
| PCT/US2000/031579 WO2001036683A2 (fr) | 1999-11-16 | 2000-11-16 | Procede d'identification rapide et precise de micro-organismes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2391571A1 true CA2391571A1 (fr) | 2001-05-25 |
Family
ID=26861776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002391571A Abandoned CA2391571A1 (fr) | 1999-11-16 | 2000-11-16 | Procede d'identification rapide et precise de micro-organismes |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1261716A2 (fr) |
| AU (1) | AU1771901A (fr) |
| CA (1) | CA2391571A1 (fr) |
| WO (1) | WO2001036683A2 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1421216A4 (fr) * | 2001-09-01 | 2006-05-17 | Samsung Electronics Co Ltd | Procede pour fabriquer une biopuce en hydrogel au moyen d'un derive de polyethyleneglycol etoile comportant un groupe epoxy |
| JP2003144153A (ja) * | 2001-11-09 | 2003-05-20 | Gifu Univ | 遺伝子検出方法、遺伝子検出用プライマー、dnaマイクロアレイ及び遺伝子検出用キット |
| US20050202414A1 (en) * | 2001-11-15 | 2005-09-15 | The Regents Of The University Of California | Apparatus and methods for detecting a microbe in a sample |
| US6881835B2 (en) * | 2002-01-04 | 2005-04-19 | Dr. Chip Biotechnology Inc. | Detection of respiratory viruses |
| DE10244456A1 (de) * | 2002-09-24 | 2004-04-15 | Hain Lifescience Gmbh | Verfahren zum Nachweis und Differenzierung von Bakterien |
| FI113549B (fi) * | 2002-11-19 | 2004-05-14 | Mobidiag Oy | Diagnostinen menetelmä hengitystieinfektioita aiheuttavien bakteerien osoittamiseksi ja tunnistamiseksi ja menetelmässä käyttökelpoinen alukeseos |
| FR2860801B1 (fr) * | 2003-10-10 | 2007-09-21 | Bertin Technologies Sa | Methode de detection rapide de micro-organismes sur puces a adn |
| US20090197249A1 (en) * | 2004-11-01 | 2009-08-06 | George Mason University | Compositions and methods for diagnosing colon disorders |
| RU2348695C2 (ru) * | 2006-05-23 | 2009-03-10 | Закрытое акционерное общество "Молекулярно-медицинские технологии" | Дифференцирующий и специфический олигонуклеотиды для идентификации последовательностей днк инфекционных агентов в биологических материалах, способ видовой идентификации инфекционных агентов, биочип и набор для осуществления этого способа |
| JP5596894B2 (ja) * | 2006-11-10 | 2014-09-24 | キヤノン株式会社 | プローブセット、プローブ固定担体及び遺伝子検査方法 |
| MX345230B (es) | 2010-02-24 | 2017-01-20 | The Broad Inst Inc * | Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos. |
| GB201314873D0 (en) * | 2013-08-20 | 2013-10-02 | Univ Cape Town | Method for diagnosing tuberculosis in a urine sample |
| EP3607096A1 (fr) * | 2017-04-03 | 2020-02-12 | Bio-Me AS | Procédés de détection de micro-organismes |
| CN119040455B (zh) * | 2024-10-31 | 2025-02-25 | 南京农业大学三亚研究院 | 高通量靶向检测反刍动物病原体及耐药基因的引物组、试剂盒及其应用 |
| CN120738374A (zh) * | 2025-08-27 | 2025-10-03 | 北京昭衍生物技术有限公司 | 一种用于检测螺原体的qPCR引物探针组合物、试剂盒及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992172A (en) * | 1987-09-14 | 1991-02-12 | Gelman Sciences, Inc. | Blotting methods using polyaldehyde activated membranes |
| US5708160A (en) * | 1995-04-26 | 1998-01-13 | The National Research Council | HSP-60 genomic locus and primers for species identification |
| US5994066A (en) * | 1995-09-11 | 1999-11-30 | Infectio Diagnostic, Inc. | Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| WO1998028444A2 (fr) * | 1996-12-23 | 1998-07-02 | The University Of Chicago | Micropuces oligonucleotidiques sur mesure utilisees comme capteurs multiples |
| DE19716456C2 (de) * | 1997-04-21 | 2002-05-08 | Schmitt Heinz Josef | Verwendung einer Kombination von Primern zum Nachweis von Erregern von Infektionskrankheiten |
| US6159949A (en) * | 1997-08-29 | 2000-12-12 | Smithkline Beecham Corporation | FtsY of Staphyloccus aureus |
-
2000
- 2000-11-16 EP EP00980462A patent/EP1261716A2/fr not_active Withdrawn
- 2000-11-16 CA CA002391571A patent/CA2391571A1/fr not_active Abandoned
- 2000-11-16 WO PCT/US2000/031579 patent/WO2001036683A2/fr not_active Ceased
- 2000-11-16 AU AU17719/01A patent/AU1771901A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001036683A2 (fr) | 2001-05-25 |
| WO2001036683A3 (fr) | 2002-09-26 |
| AU1771901A (en) | 2001-05-30 |
| EP1261716A2 (fr) | 2002-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6656689B2 (en) | Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms | |
| KR101038519B1 (ko) | 인체 감염성질환 병원체 감별진단 및 이의 항생제 내성 유무 판별방법, 멀티플렉스 키트 그리고 이를 포함하는 칩 | |
| US20060160121A1 (en) | Probe arrays for detecting multiple strains of different species | |
| US20130157876A1 (en) | Systems and Methods for Detecting Antibiotic Resistance | |
| US20060046246A1 (en) | Genus, group, species and/or strain specific 16S rDNA sequences | |
| CA2391571A1 (fr) | Procede d'identification rapide et precise de micro-organismes | |
| US20030134293A1 (en) | Method for rapid and accurate identification of microorganisms | |
| US5536638A (en) | Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae | |
| CN101287844A (zh) | 用于检测和/或鉴定微生物的方法 | |
| US7659388B2 (en) | Method and compositions for detecting respiratory disease-causing bacterial species | |
| JPH08510920A (ja) | Haemophilusinfluenzaeを検出するための核酸プローブ | |
| US20040253617A1 (en) | Molecular typing of group B streptococci | |
| JP2006509500A (ja) | トポイソメラーゼ遺伝子の領域からの核酸プローブ及びブロードレンジプライマー並びにそれらを使用する方法 | |
| CA2428646A1 (fr) | Groupe et utilisations connexes | |
| EP1725681A2 (fr) | Dosage pour la detection et l'identification de micro-organismes | |
| KR100973435B1 (ko) | 식중독균 검출용 올리고뉴클레오티드 프로브 세트 및 상기프로브 세트를 포함하는 마이크로어레이 | |
| EP1739193A2 (fr) | Sérotypage de Salmonella | |
| EP1466011B1 (fr) | Nouvelles amorces pour la detection et l'identification de groupes d'indicateurs bacteriens | |
| US20100167951A1 (en) | Dna chip for detection of staphylococcus aureus | |
| KR20090124021A (ko) | 엔테로박테리아 속 식중독균 검출용 올리고뉴클레오티드프로브 세트 및 상기 프로브 세트를 포함하는마이크로어레이 | |
| KR100617647B1 (ko) | 아시네토박터 바우마니 균의 검출용 dna 칩 | |
| KR100973432B1 (ko) | 바실랄레스 목 식중독균 검출용 올리고뉴클레오티드 프로브세트 및 상기 프로브 세트를 포함하는 마이크로어레이 | |
| KR20070069680A (ko) | 스타필로코코스 아우레우스 검출용 dna 칩 | |
| KR20030087912A (ko) | Its로부터 유도된 세균성 감염질환 원인균의 검출용dna탐침 | |
| KR20030087913A (ko) | 23S rRNA 유전자로부터 유도된 세균성 감염질환원인균의 검출용 DNA 탐침 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |